About Q-linea AB 
Q-linea AB
Pharmaceuticals & Biotechnology
Q linea AB is a Sweden-based medical technology company. The Company develops and manufactures in-vitro diagnostic (IVD) solutions for infectious diseases. The Company's core product candidate is ASTar, a fully-automated instrument for Antibiotic Susceptibility Testing (AST). It measures bacteria's antimicrobial susceptibility using the disposables developed by the Company. It is able to provide a susceptibility profile within three to six hours directly from a positive blood culture, which enables early administration of antibiotics specifically targeting the disease-causing pathogen. Its main application is the identification of sepsis in hospital patients and the product is aimed primarily at hospital laboratories.
Company Coordinates 
Company Details
Dag Hammarskjolds Vag 52 A , UPPSALA None : 752 37
Registrar Details
Shareholding Snapshot
No data for shareholding present.
Shareholding Compare (%holding) 
No data for shareholding present.
Management
Designation
Ms. Erika Kjellberg Eriksson
Chairman of the Board
Mr. Ulf Landegren
Director
Mr. Mats Nilsson
Director
Mr. Marcus Storch
Director
Dr. Marianne Hansson
Independent Director
Mr. Hans Johansson
Independent Director
Revenue and Profits:
Net Sales:
1 Million
(Quarterly Results - Jun 2025)
Net Profit:
-48 Million
Pharmaceuticals & Biotechnology
SEK 498 Million (Micro Cap)
NA (Loss Making)
NA
0.00%
0.03
-215.40%
5.70






